These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3422167)

  • 21. The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study Group.
    Schoch C; Haase D; Fonatsch C; Haferlach T; Löffler H; Schlegelberger B; Hossfeld DK; Becher R; Sauerland MC; Heinecke A; Wörmann B; Büchner T; Hiddemann W
    Br J Haematol; 1997 Dec; 99(3):605-11. PubMed ID: 9401073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance).
    Niederwieser C; Nicolet D; Carroll AJ; Kolitz JE; Powell BL; Kohlschmidt J; Stone RM; Byrd JC; Mrózek K; Bloomfield CD
    Haematologica; 2016 Dec; 101(12):1516-1523. PubMed ID: 27470602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome aberrations in CD34-positive acute myeloid leukemia. Correlation with clinicopathologic features.
    Fagioli F; Cuneo A; Carli MG; Bardi A; Piva N; Previati R; Rigolin GM; Ferrari L; Spanedda R; Castoldi G
    Cancer Genet Cytogenet; 1993 Dec; 71(2):119-24. PubMed ID: 7506635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: a Southwest Oncology Group study (SWOG-8612).
    Slovak ML; Kopecky KJ; Wolman SR; Henslee-Downey JP; Appelbaum FR; Forman SJ; Blume KG
    Leuk Res; 1995 Jun; 19(6):381-8. PubMed ID: 7596150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive profile of cytogenetics in 2308 Chinese children and adults with de novo acute myeloid leukemia.
    Li X; Li X; Xie W; Hu Y; Li J; Du W; Liu W; Li H; Chen X; Zhang L; Wang J; Huang S
    Blood Cells Mol Dis; 2012 Aug; 49(2):107-13. PubMed ID: 22683308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytogenetic survey of 80 patients with acute nonlymphocytic leukemia.
    Palka G; Calabrese G; Fioritoni G; Stuppia L; Guanciali Franchi P; Marino M; Antonucci A; Spadano A; Torlontano G
    Cancer Genet Cytogenet; 1992 Mar; 59(1):45-50. PubMed ID: 1555190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Core binding factor acute myeloid leukaemia and c-KIT mutations.
    Riera L; Marmont F; Toppino D; Frairia C; Sismondi F; Audisio E; Di Bello C; D'Ardia S; Di Celle PF; Messa E; Inghirami G; Vitolo U; Pich A
    Oncol Rep; 2013 May; 29(5):1867-72. PubMed ID: 23467883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there still a role for low-dose cytosine arabinoside in de novo acute myeloid leukemia in the elderly? A report on 77 cases.
    Detourmignies L; Wattel E; Laï JL; Bauters F; Fenaux P
    Ann Hematol; 1993 May; 66(5):235-40. PubMed ID: 8507718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic study of 130 patients with acute nonlymphocytic leukemia.
    Michalová K; Musilová J; Zemanová Z
    Neoplasma; 1990; 37(3):283-91. PubMed ID: 2370915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML.
    Sperling C; Büchner T; Creutzig U; Ritter J; Harbott J; Fonatsch C; Sauerland C; Mielcarek M; Maschmeyer G; Löffler H
    Leuk Lymphoma; 1995 May; 17(5-6):417-26. PubMed ID: 7549832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
    Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
    Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of 32 cases of acute leukemia with abnormality of chromosome 7].
    Lu Y; Jin J; Chen ZM; Lou JY; Xu WL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):596-9. PubMed ID: 15583990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effectiveness analysis of HA based triple-drug regimen as induction chemotherapy in the treatment of acute myeloid leukemia and its relationship with karyotype].
    Mi YC; Xue YP; Yu WJ; Liu SH; Zhao YZ; Meng QX; Bian SG; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):705-9. PubMed ID: 16620570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia.
    Bochtler T; Stölzel F; Heilig CE; Kunz C; Mohr B; Jauch A; Janssen JW; Kramer M; Benner A; Bornhäuser M; Ho AD; Ehninger G; Schaich M; Krämer A
    J Clin Oncol; 2013 Nov; 31(31):3898-905. PubMed ID: 24062393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML.
    Preiss BS; Bergmann OJ; Friis LS; Sørensen AG; Frederiksen M; Gadeberg OV; Mourits-Andersen T; Oestergaard B; Kerndrup GB;
    Cancer Genet Cytogenet; 2010 Oct; 202(2):108-22. PubMed ID: 20875873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetic Studies in Patients with Acute Myeloid Leukemia Following a Myelodysplastic Syndrome.
    Weh HJ; Kuse R; Seeger D; Suciu S; Hossfeld DK
    Leuk Lymphoma; 1991; 3(5-6):423-7. PubMed ID: 27467434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
    Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
    Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
    Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
    J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trisomy 21 with t(5; 11) chromosomal translocation as new unfavorable cytogenetic abnormalities in pediatric acute myeloid leukemia type M2: One case report of nine-year follow-up and literature review.
    Wang L; Wu XY; Jin RM; Zhang BY; Qiu YN
    J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):807-810. PubMed ID: 29058300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0).
    Stasi R; Del Poeta G; Venditti A; Masi M; Stipa E; Dentamaro T; Cox C; Dallapiccola B; Papa G
    Blood; 1994 Mar; 83(6):1619-25. PubMed ID: 8123853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.